[Novel antibiotics active against Gram-positive bacteria].
Garcia Sánchez
J E
JE
Fresnadillo Martínez
M J
MJ
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D001372:Aza Compounds; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D024841:Fluoroquinolones; D000077734:Gatifloxacin; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D000077266:Moxifloxacin; D010455:Peptides; D011804:Quinolines
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D010455:Peptides; D011804:Quinolines; D000077734:Gatifloxacin; D000077266:Moxifloxacin